This dual-binding mechanism facilitated the formation of a two-way adaptors between macrophages and tumor cells, promoting M1 polarization of TAMs and disrupting the CD47–SIRPα signaling axis to restore macrophage phagocytic activity (Feng et al., 2022). The gene discussed is CD47; the disease is neoplasm.